Un exemple d’investigation d’un phénomène « émergent » en addictovigilance : à propos du méthylphénidate
Therapie, 70 2 (2015) 191-196
Published online: 2015-04-09
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Addictovigilance: The Edge of reason?
Maryse Lapeyre-Mestre, Joelle Micallef, Amélie Daveluy, Reynald Le Boisselier, Célian Bertin, Nathalie Fouilhe Sam-Lai, Régis Bordet, Alexandra Boucher, Joëlle Micallef, Hélène Peyrière, Pierre Gillet, Caroline Victorri-Vigneau, Anne Batisse, Marie-Christine Perault-Pochat and Maryse Lapeyre-MestreTherapies 80 (2) 155 (2025)
https://doi.org/10.1016/j.therap.2025.01.001
From the first pilot initiatives in the early 1990s to the national OSIAP survey in the 2020s: More than 30 years of insight in medication diversion phenomenon in France
Maryse Lapeyre-Mestre, Florence Fabre and Emilie JouanjusTherapies 80 (2) 163 (2025)
https://doi.org/10.1016/j.therap.2024.10.053
From regional signal to alert in addictovigilance
Amélie Daveluy, Justine Perino, Valérie Gibaja, Reynald Le Boisselier, Anne Batisse, Ghada Miremont-Salamé, Alexandre Peyré, Alexandra Boucher, Elisabeth Frauger, Joëlle Micallef and Hélène PeyrièreTherapies 80 (2) 213 (2025)
https://doi.org/10.1016/j.therap.2024.10.056
Détection et quantification du méthylphénidate et de l’acide ritalinique dans les matrices kératinisées
Morgane Baudry, Alice Ameline, Jean-Sébastien Raul and Pascal KintzToxicologie Analytique et Clinique 36 (3) 297 (2024)
https://doi.org/10.1016/j.toxac.2023.11.004
Analyse des seringues usagées : un reflet de la consommation de substances psychoactives par les usagers de drogues par voie intraveineuse ?
Sandra Nordmann, Thomas Nefau, Joëlle Micallef, Catherine Duplessy, Jean-Christophe Catusse and Elisabeth FraugerTherapies 78 (5) S51 (2023)
https://doi.org/10.2515/therapie/2015054
Augmentation de l’abus de méthylphénidate : repérage et profils sur 13 années
Clémence Guerra, Thomas Soeiro, Clémence Lacroix, Elisabeth Jouve, Joelle Micallef and Elisabeth FraugerTherapies 77 (6) 713 (2022)
https://doi.org/10.1016/j.therap.2022.03.006
Addictovigilance contribution during COVID-19 epidemic and lockdown in France
Maryse Lapeyre-Mestre, Alexandra Boucher, Amélie Daveluy, Valérie Gibaja, Emilie Jouanjus, Michel Mallaret, Helene Peyrière, Joëlle Micallef, Emilie Bouquet, Leila Chaouachi, Cécile Chevallier, Sylvie Deheul, Céline Eiden, Nathalie Fouilhé, Chistine Fournier-Choma, Elisabeth Frauger, Marylène Guerlais, Reynald Le Boisselier, Ghada Miremont, Anne Roussin and Juliana TournebizeTherapies 75 (4) 343 (2020)
https://doi.org/10.1016/j.therap.2020.06.006
Détection des signaux du réseau français d’addictovigilance : méthodes innovantes d’investigation, illustrations et utilité pour la santé publique
Joëlle Micallef, Émilie Jouanjus, Michel Mallaret and Maryse Lapeyre MestreTherapies 74 (6) 579 (2019)
https://doi.org/10.1016/j.therap.2019.09.005
Prescriptions hors AMM supervisées de méthylphénidate dans le TDAH de l’adulte
L. Carton, T. Dondaine, S. Deheul, C. Marquié, F. Brigadeau, A. Amad, D. Devos, T. Danel, R. Bordet, O. Cottencin, S. Gautier and O. MénardL'Encéphale 45 (1) 74 (2019)
https://doi.org/10.1016/j.encep.2018.05.008
Reply to ‘Overuse or underuse of methylphenidate in adults in France: commentary on Pauly et al. 2018’ by Weibel et al.
Vanessa Pauly, Elisabeth Frauger, Marion Lepelley, Michel Mallaret, Quentin Boucherie and Joelle MicallefBritish Journal of Clinical Pharmacology 85 (1) 275 (2019)
https://doi.org/10.1111/bcp.13776
Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution
Mathilde Dupui, Joëlle Micallef and Maryse Lapeyre-MestreTherapies 74 (2) 307 (2019)
https://doi.org/10.1016/j.therap.2018.09.078
Methods in pharmacoepidemiology
Agnès Sommet and Antoine ParienteTherapies 74 (2) 187 (2019)
https://doi.org/10.1016/j.therap.2018.11.015
Tamper‐resistant prescription forms for narcotics in France: Should we generalize them?
Amélie Daveluy, Lucie Sauvaget, Angela Bastien, Maryse Lapeyre‐Mestre, Cédric Collin, Nathalie Richard and Françoise HaramburuFundamental & Clinical Pharmacology 32 (5) 571 (2018)
https://doi.org/10.1111/fcp.12368
Pharmaceutical cognitive doping in students: A chimeric way to get-a-head?
Louise Carton, Nicolas Cabé, Olivier Ménard, et al.Therapies 73 (4) 331 (2018)
https://doi.org/10.1016/j.therap.2018.02.005
Medical prescriptions falsified by the patients: a 12‐year national monitoring to assess prescription drug diversion
Emilie Jouanjus, Grégory Guernec and Maryse Lapeyre‐MestreFundamental & Clinical Pharmacology 32 (3) 306 (2018)
https://doi.org/10.1111/fcp.12356
Doctor shopping of opioid analgesics relative to benzodiazepines: A pharmacoepidemiological study among 11.7 million inhabitants in the French countries
Camille Ponté, Marion Lepelley, Quentin Boucherie, et al.Drug and Alcohol Dependence 187 88 (2018)
https://doi.org/10.1016/j.drugalcdep.2018.01.036
Patterns and profiles of methylphenidate use both in children and adults
Vanessa Pauly, Elisabeth Frauger, Magalie Lepelley, Michel Mallaret, Quentin Boucherie and Joëlle MicallefBritish Journal of Clinical Pharmacology 84 (6) 1215 (2018)
https://doi.org/10.1111/bcp.13544
Dopage cognitif chez les étudiants : un moyen chim(ér)ique de s’en mettre plein la tête ?
Louise Carton, Nicolas Cabé, Olivier Ménard, et al.Therapies 73 (4) 319 (2018)
https://doi.org/10.1016/j.therap.2017.10.006
Profils d’exposition au méthylphénidate à l’âge adulte
Vanessa Pauly, Elisabeth Frauger, Marion Lepelley, Michel Mallaret and Joëlle MicallefTherapies 73 (6) 571 (2018)
https://doi.org/10.1016/j.therap.2018.09.011
Comment on: "Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter"
Emilie Jouanjus, Michel Mallaret, Joëlle Micallef, et al.Drug Safety 40 (2) 183 (2017)
https://doi.org/10.1007/s40264-016-0497-7
Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM survey
Amélie Daveluy, Elisabeth Frauger, Hélène Peyrière, Christophe Moracchini, Françoise Haramburu and Joëlle MicallefFundamental & Clinical Pharmacology 31 (1) 126 (2017)
https://doi.org/10.1111/fcp.12233
Symptômes psychiatriques aigus lors d’injections intraveineuses de méthylphénidate : à propos d’un cas
Fabrice Vérité and Joëlle MicallefTherapies 72 (3) 367 (2017)
https://doi.org/10.1016/j.therap.2016.10.002
Methylphenidate: Gender trends in adult and pediatric populations over a 7 year period
Carole Ehrhardt, Quentin Boucherie, Vanessa Pauly, et al.Therapies 72 (6) 635 (2017)
https://doi.org/10.1016/j.therap.2017.05.005
Cocaïne et méthylphénidate : quelques données épidémiologiques
Perrine RouxPsychotropes Vol. 21 (4) 41 (2016)
https://doi.org/10.3917/psyt.214.0041
The consequences of drug misuse on post-marketing surveillance
Fabrizio Schifano, Gabriele Duccio Papanti, Laura Orsolini and John Martin CorkeryExpert Review of Clinical Pharmacology 9 (7) 867 (2016)
https://doi.org/10.1080/17512433.2016.1178571
Système de surveillance en addictovigilance : quelles données pharmacoépidémiologiques à l'échelle de l'Europe ?
Maryse Lapeyre-Mestre and Mathilde DupuiTherapies 70 (2) 147 (2015)
https://doi.org/10.2515/therapie/2015006
Comment identifier un signal en addictovigilance ?
Emilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu and Amélie DaveluyTherapies 70 (2) 113 (2015)
https://doi.org/10.2515/therapie/2015009